Choosing Wisely in oncology: are guidelines effective at preventing unnecessary diagnostics? The example of surveillance positron emission tomography for patients with localised colorectal cancer
Despite the professional guidelines recommending against routine PETCT to monitor for recurrence following curative-intent treatment of CRC, there remains a large volume of guideline-discordant PETCTs, constituting healthcare overuse of an expensive diagnostic procedure.
Authors
- Daniel A. Goldstein (ORCID: https://orcid.org/0000-0002-8082-9622)
- Ronen Arbel (ORCID: https://orcid.org/0000-0002-6058-8665)
- Idan Menashe (ORCID: https://orcid.org/0000-0003-1961-1461)
- Roi Tschernichovsky (ORCID: https://orcid.org/0000-0002-3539-1940)
- Doron Netzer (ORCID: https://orcid.org/0009-0000-0466-7310)
- Keren Filosof
- Talish Razi (ORCID: https://orcid.org/0009-0006-2172-1044)
Institutions
- Ben-Gurion University of the Negev (IL)
- Sapir College (IL)
- Tel Aviv University (IL)
- Rabin Medical Center (IL)
- Weizmann Institute of Science (IL)
- Clalit Health Services (IL)
Publication Details
- Journal
- BMJ Oncology
- Published
- 2024-08-01
- DOI
- https://doi.org/10.1136/bmjonc-2024-000391
- Primary Topic
- Healthcare cost, quality, practices
- Type
- article
- Field-Weighted Citation Impact
- 0.00